ArticleScience translational medicine2023

Selective Bcl-2 inhibition promotes hematopoietic chimerism and allograft tolerance without myelosuppression in nonhuman primates.

Hajime Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.